Application of Interferon Alpha 2b in Conjunctival Intraepithelial Neoplasia: Predictors and Prognostic Factors

2014 ◽  
Vol 30 (6) ◽  
pp. 489-494 ◽  
Author(s):  
José Enrique Muñoz de Escalona Rojas ◽  
José Luis García Serrano ◽  
Jesús Cantero Hinojosa ◽  
José Francisco Padilla Torres ◽  
Rosa María Bellido Muñoz
Cornea ◽  
2002 ◽  
Vol 21 (1) ◽  
pp. 6-11 ◽  
Author(s):  
Barry A. Schechter ◽  
Amilia Schrier ◽  
Robert S. Nagler ◽  
Edward F. Smith ◽  
Gabriel E. Velasquez

2009 ◽  
Vol 94 (1) ◽  
pp. 134-135 ◽  
Author(s):  
E E Gabison ◽  
A Labbe ◽  
F Brignole-Baudouin ◽  
H Nourry ◽  
M Putterman ◽  
...  

1994 ◽  
Vol 37 (3) ◽  
pp. 204-209 ◽  
Author(s):  
Giuseppe Gioele Garzetti ◽  
Andrea Ciavattini ◽  
Carlo Romanini ◽  
Gaia Goteri ◽  
Andrea Luigi Tranquilli ◽  
...  

2021 ◽  
Author(s):  
Hossein Aghaei ◽  
Acieh Es'haghi ◽  
Sanam Alilou ◽  
Shirin Rafatnia

We describe a 34-year-old woman with isolated tuberculosis (TB) uveitis who had unsuccessful resolution of her ocular surface squamous neoplasia after multiple shave excisions with a positive purified protein derivative (PPD) test and interferon-gamma (IFN-γ) release assays (IGRAs) proven tuberculosis. She was managed with wide local excision of the lesion. Histopathology confirmed conjunctival intraepithelial neoplasia (CIN) grade II. Topical interferon alpha-2b (4 times daily) and anti-tuberculous therapy was planned for her, and there was no sign of recurrence of the lesion at six months follow-up.


Sign in / Sign up

Export Citation Format

Share Document